• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings

    7/18/24 10:04:45 AM ET
    $AGEN
    $CHUY
    $DHI
    $FTEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Restaurants
    Consumer Discretionary
    Get the next $AGEN alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones index gaining around 40 points on Thursday.

    Following the market opening Thursday, the Dow traded up 0.10% to 41,238.64 while the NASDAQ rose 0.22% to 18,036.66. The S&P 500 also rose, gaining, 0.21% to 5,600.18.

    Check This Out: Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July

    Leading and Lagging Sectors

    Industrials shares jumped by 0.6% on Thursday.

    In trading on Thursday, health care shares fell by 0.4%.

    Top Headline

    D.R. Horton, Inc. (NYSE:DHI) reported better-than-expected second-quarter earnings on Thursday.

    D.R. reported quarterly earnings of $4.10 per share which beat the analyst consensus estimate of $3.78 per share. The company reported quarterly sales of $9.966 billion which beat the analyst consensus estimate of $9.771 billion.

    Equities Trading UP
                           

    • Onconetix, Inc. (NASDAQ:ONCO) shares shot up 85% to $0.2761. On July 15, Onconetix announced closing of warrant exercise for $1.11 million gross proceeds.
    • Shares of Silo Pharma, Inc. (NASDAQ:SILO) got a boost, surging 66% to $3.74. Silo Pharma said it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider.
    • Chuy’s Holdings, Inc. (NASDAQ:CHUY) shares were also up, gaining 48% to $37.35 after Darden Restaurants announced it will acquire the company.

    Equities Trading DOWN

    • Agenus Inc. (NASDAQ:AGEN) shares dropped 54% to $8.17 after the company announced the FDA discouraged an accelerated approval pathway at the end-of-Phase 2 meeting.
    • Shares of Leslie’s, Inc. (NASDAQ:LESL) were down 30% to $2.8699 after the company reported preliminary financial results for the third quarter and cut its full-year guidance. Multiple analysts also lowered price targets on the stock Thursday morning.
    • Fitell Corporation (NASDAQ:FTEL) was down, falling 22% to $21.00.

    Also Check This Out: Nvidia, Electronic Arts And 2 Other Stocks Insiders Are Selling

    Commodities

    In commodity news, oil traded down 0.3% to $82.60 while gold traded up 0.3% at $2,467.00.

    Silver traded up 0.6% to $30.565 on Thursday, while copper fell 2.1% to $4.3175.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 rose 0.6%, Germany's DAX rose 0.4% and France's CAC 40 rose 0.9%. Spain's IBEX 35 Index rose 0.9%, while London's FTSE 100 rose 0.8%.

    Construction output in the Eurozone fell 2.4% year-over-year in May compared to a revised 1.5% decline in the prior month. Passenger car registrations in the European Union climbed 4.3% year-over-year to 1.1 million units in June.

    Regular pay in the U.K., excluding bonus payment, rose 5.7% year-over-year to GBP 643/week during the three months to May, while the unemployment rate came in unchanged at 4.4% from March to May.

    Asia Pacific Markets

    Asian markets closed mixed on Thursday, with Japan's Nikkei 225 dipping 2.36%, Hong Kong's Hang Seng Index gaining 0.22%, China's Shanghai Composite Index gaining 0.48% and India's S&P BSE Sensex climbing 0.78%.

    Hong Kong’s unemployment rate came in unchanged at 3% during the three months ending June. Japan reported a trade surplus of JPY 224.04 billion in June, compared to market views for a deficit of JPY 240 billion.

    Economics

    • U.S. initial jobless claims increased by 10,000 to 243,000 in the week ending July 13, compared to market estimates of 230,000.
    • The Philadelphia Fed Manufacturing Index rose to 13.9 in July, recording the strongest level in three months, versus 1.3 in June.

    Now Read This:

    • How To Earn $500 A Month From American Express Stock Ahead Of Q2 Earnings
    Get the next $AGEN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGEN
    $CHUY
    $DHI
    $FTEL

    CompanyDatePrice TargetRatingAnalyst
    Leslie's Inc.
    $LESL
    1/15/2026$1.50Equal-Weight → Underweight
    Morgan Stanley
    D.R. Horton Inc.
    $DHI
    1/7/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    D.R. Horton Inc.
    $DHI
    1/6/2026$155.00Overweight → Equal Weight
    Wells Fargo
    D.R. Horton Inc.
    $DHI
    12/2/2025$186.00Buy
    BTIG Research
    D.R. Horton Inc.
    $DHI
    10/7/2025$169.00Outperform → In-line
    Evercore ISI
    Agenus Inc.
    $AGEN
    6/4/2025$25.00Neutral → Buy
    H.C. Wainwright
    Leslie's Inc.
    $LESL
    4/25/2025Sell → Hold
    Stifel
    D.R. Horton Inc.
    $DHI
    3/6/2025$164.00Neutral → Buy
    Seaport Research Partners
    More analyst ratings

    $AGEN
    $CHUY
    $DHI
    $FTEL
    SEC Filings

    View All

    Onconetix Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Onconetix, Inc. (0001782107) (Filer)

    2/9/26 5:00:25 PM ET
    $ONCO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Leslie's Inc.

    DEFA14A - Leslie's, Inc. (0001821806) (Filer)

    2/2/26 4:28:36 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    SEC Form DEF 14A filed by Leslie's Inc.

    DEF 14A - Leslie's, Inc. (0001821806) (Filer)

    2/2/26 4:24:23 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    $AGEN
    $CHUY
    $DHI
    $FTEL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOT/BAL in Immunologically Cold Tumors

    Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology, today announced that new translational and clinical biomarker analyses from its botensilimab (BOT) immunotherapy program have been accepted for poster presentation at the American Association for Cancer Research- Immuno-Oncology (AACR-IO) Conference, taking place in Los Angeles, CA on February 18–21, 2026. The abstract, titled "Systemic and tumor-microenvironment inflammation shape outcomes in patients with immunologically cold, treatment-refractory tumors treated with Fc-enhanced anti–CTLA-4 botensilimab," evaluates how systemic inflammatory markers, tumor microenvironment (TME) immune activity, and peripheral immune cell states are

    2/9/26 1:00:00 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Fitell Corporation Appoints AI and Robotics Executive Jack Zeng as Head of Technology at 2F Robotics to Accelerate Development and Commercialization Strategy

    Sydney, Australia, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Fitell Corporation (NASDAQ:FTEL) ("Fitell" or the "Company") announced today the appointment of Jack Zeng as the Head of Technology of 2F Robotics Pty Ltd, Fitell's robotics-focused subsidiary. Before joining Fitell, Mr. Zeng has founded and scaled successful technology ventures and brought experience in building data analytics and intelligent agent solutions for major enterprise customers including Fortune 500 across Asia, spanning product research and development, deployment, and go-to-market. With a background encompassing top-tier computer science education, Microsoft-certified engineering, and successful AI ventures, he has a track

    2/4/26 8:30:00 AM ET
    $FTEL
    Recreational Games/Products/Toys
    Consumer Discretionary

    Leslie's, Inc. to Report First Quarter 2026 Financial Results on February 17, 2026

    PHOENIX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Leslie's, Inc. (NASDAQ:LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced it will release its first quarter 2026 financial results after market close on Tuesday, February 17, 2026. The company will host a conference call at 5:00 p.m. Eastern time on February 17, 2026 to discuss the financial results as well as progress against the company's strategic transformation initiatives. A live webcast of the conference call will be available online at https://ir.lesliespool.com/. A replay of the conference call will be availab

    2/3/26 4:15:00 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    $AGEN
    $CHUY
    $DHI
    $FTEL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Armen Garo H was granted 5,027 shares, increasing direct ownership by 2% to 320,712 units (SEC Form 4)

    4 - AGENUS INC (0001098972) (Issuer)

    2/9/26 4:05:03 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Officer Lindquist Benjamin covered exercise/tax liability with 7 shares and converted options into 19 shares, increasing direct ownership by 0.79% to 1,533 units (SEC Form 4)

    4 - Leslie's, Inc. (0001821806) (Issuer)

    1/29/26 4:15:02 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    Officer Armen Garo H was granted 4,562 shares, increasing direct ownership by 1% to 315,685 units (SEC Form 4)

    4 - AGENUS INC (0001098972) (Issuer)

    1/26/26 4:05:04 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGEN
    $CHUY
    $DHI
    $FTEL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Weisblum Eric bought $2,075 worth of shares (5,000 units at $0.41), increasing direct ownership by 2% to 216,932 units (SEC Form 4)

    4 - Silo Pharma, Inc. (0001514183) (Issuer)

    12/16/25 6:34:59 PM ET
    $SILO
    Apparel
    Consumer Discretionary

    Chief Executive Officer Weisblum Eric bought $735 worth of shares (2,000 units at $0.37), increasing direct ownership by 0.95% to 211,932 units (SEC Form 4)

    4 - Silo Pharma, Inc. (0001514183) (Issuer)

    11/21/25 6:35:50 PM ET
    $SILO
    Apparel
    Consumer Discretionary

    Chief Executive Officer Weisblum Eric bought $4,847 worth of shares (12,000 units at $0.40), increasing direct ownership by 6% to 209,932 units (SEC Form 4)

    4 - Silo Pharma, Inc. (0001514183) (Issuer)

    11/20/25 4:00:32 PM ET
    $SILO
    Apparel
    Consumer Discretionary

    $AGEN
    $CHUY
    $DHI
    $FTEL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Leslie's downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Leslie's from Equal-Weight to Underweight and set a new price target of $1.50

    1/15/26 8:33:55 AM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    D.R. Horton downgraded by Citizens JMP

    Citizens JMP downgraded D.R. Horton from Mkt Outperform to Mkt Perform

    1/7/26 8:55:45 AM ET
    $DHI
    Homebuilding
    Consumer Discretionary

    D.R. Horton downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded D.R. Horton from Overweight to Equal Weight and set a new price target of $155.00

    1/6/26 8:45:39 AM ET
    $DHI
    Homebuilding
    Consumer Discretionary

    $AGEN
    $CHUY
    $DHI
    $FTEL
    Leadership Updates

    Live Leadership Updates

    View All

    Fitell Corporation Appoints AI and Robotics Executive Jack Zeng as Head of Technology at 2F Robotics to Accelerate Development and Commercialization Strategy

    Sydney, Australia, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Fitell Corporation (NASDAQ:FTEL) ("Fitell" or the "Company") announced today the appointment of Jack Zeng as the Head of Technology of 2F Robotics Pty Ltd, Fitell's robotics-focused subsidiary. Before joining Fitell, Mr. Zeng has founded and scaled successful technology ventures and brought experience in building data analytics and intelligent agent solutions for major enterprise customers including Fortune 500 across Asia, spanning product research and development, deployment, and go-to-market. With a background encompassing top-tier computer science education, Microsoft-certified engineering, and successful AI ventures, he has a track

    2/4/26 8:30:00 AM ET
    $FTEL
    Recreational Games/Products/Toys
    Consumer Discretionary

    Leslie's, Inc. Appoints John Hartmann to Board of Directors

    PHOENIX, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Leslie's, Inc. ((", Leslie', s", or the "Company", NASDAQ:LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, announced that it has appointed John Hartmann as an independent director to its Board of Directors, effective January 7, 2026. Mr. Hartmann brings nearly 25 years of retail leadership experience where he has executed successful turnaround as a C-suite executive of both public and private companies across diverse industries, including home improvement and home furnishings. He has joined the Board as a Class III Director and will

    1/8/26 8:30:00 AM ET
    $BGSI
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France's AAC

    Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology innovation, today announced the appointment of José Iglesias, M.D. as Chief Medical Affairs Officer, effective November 10, 2025. Dr. Iglesias will lead global medical affairs for botensilimab (BOT) and balstilimab (BAL) as the combination advances through Phase 3 evaluation and becomes available in selected countries through early-access mechanisms, including France's Autorisation d'Accès Compassionnel (AAC) program. BOT is an Fc-enhanced multifunctional CTLA-4 antibody and BAL is a PD-1 antibody. In combination, BOT/BAL is being investigated in patients with microsatellite-stable colorectal cancer (MSS CRC), a population that has hi

    11/18/25 8:41:00 AM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGEN
    $CHUY
    $DHI
    $FTEL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Agenus Inc.

    SC 13G/A - AGENUS INC (0001098972) (Subject)

    11/14/24 7:58:18 PM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Onconetix Inc.

    SC 13G - Onconetix, Inc. (0001782107) (Subject)

    11/14/24 11:19:35 AM ET
    $ONCO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Agenus Inc.

    SC 13G/A - AGENUS INC (0001098972) (Subject)

    11/14/24 9:21:26 AM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGEN
    $CHUY
    $DHI
    $FTEL
    Financials

    Live finance-specific insights

    View All

    Leslie's, Inc. to Report First Quarter 2026 Financial Results on February 17, 2026

    PHOENIX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Leslie's, Inc. (NASDAQ:LESL), the largest and most trusted direct-to-customer brand in the U.S. pool and spa care industry serving residential customers and pool professionals nationwide, today announced it will release its first quarter 2026 financial results after market close on Tuesday, February 17, 2026. The company will host a conference call at 5:00 p.m. Eastern time on February 17, 2026 to discuss the financial results as well as progress against the company's strategic transformation initiatives. A live webcast of the conference call will be available online at https://ir.lesliespool.com/. A replay of the conference call will be availab

    2/3/26 4:15:00 PM ET
    $LESL
    Other Specialty Stores
    Consumer Discretionary

    D.R. Horton, Inc., America's Builder, Reports Fiscal 2026 First Quarter Earnings and Declares Quarterly Dividend of $0.45 Per Share

    D.R. Horton, Inc. (NYSE:DHI), America's Builder, today reported its first fiscal quarter results. All comparisons in this release are to the respective prior year period, unless noted otherwise. Fiscal 2026 First Quarter Highlights As of or for the quarter ended December 31, 2025 Net income attributable to D.R. Horton of $594.8 million or $2.03 per diluted share Consolidated pre-tax income of $798.1 million, with a pre-tax profit margin of 11.6% Consolidated revenues of $6.9 billion Home sales revenues of $6.5 billion on 17,818 homes closed Net sales orders increased 3% to 18,300 homes with an order value of $6.7 billion Cash provided by operations totaled $854.0 million

    1/20/26 6:30:00 AM ET
    $DHI
    Homebuilding
    Consumer Discretionary

    D.R. Horton, Inc. to Release 2026 First Quarter Earnings on January 20, 2026

    As previously announced, D.R. Horton, Inc. (NYSE:DHI), America's Builder, will release financial results for its first quarter ended December 31, 2025 on Tuesday, January 20, 2026 before the market opens. The Company will host a conference call that morning at 8:30 a.m. Eastern Time (ET). The dial-in number is 888-506-0062. When calling, please reference access code 729287. Participants are encouraged to call in five minutes before the call begins (8:25 a.m. ET). The call will also be webcast from the Company's website at investor.drhorton.com. A replay of the call will be available after 12:30 p.m. ET on Tuesday, January 20, 2026 at 877-481-4010. When calling, please reference replay pass

    12/18/25 9:00:00 AM ET
    $DHI
    Homebuilding
    Consumer Discretionary